Summary of Teladoc Conference Call Company Overview - **Company**: Teladoc Health - **CEO**: Chuck Divita - **Industry**: Telehealth and Integrated Care Key Points CEO Tenure and Company Performance - Chuck Divita reflects on his two-year tenure, noting both strengths and challenges faced at Teladoc, emphasizing the need for increased strategic focus, operational rigor, and product innovation [4] - The company aims to strengthen its position heading into 2026, particularly focusing on BetterHelp, which constitutes about 40% of revenues [4] CFO Search - The search for a new CFO is ongoing, with a focus on finding a candidate with financial expertise and operational rigor [5] Integrated Care Business Performance - Integrated Care has shown low- to mid-single-digit growth with EBITDA margins in the low double-digit to mid-teens range [6] - The business is transitioning from a subscription-based model to a fee-for-service model, driven by market demand for visit-based arrangements [7][24] - The company has seen good underlying growth in visit revenues, particularly in chronic care, which has experienced enrollment growth [9][8] Membership and Guidance - Teladoc has approximately 100 million members, with a projected low single-digit decline in membership for the year due to external healthcare factors [10][14] - Membership has grown by about 40% since 2020, but challenges such as Medicaid redeterminations and changes in the Affordable Care Act may impact retention [15] Chronic Care Segment - Sequential growth in chronic care enrollment is expected, with opportunities for upselling and engaging new members [17][20] - The company aims to penetrate its existing member base more deeply, particularly in weight management services [21] BetterHelp Business Update - BetterHelp has faced volatility but is expected to stabilize as the company pivots towards insurance coverage, which is anticipated to drive growth [30][31] - The direct-to-consumer cash pay model has seen high drop-off rates, with over 80% of potential users not converting due to cost barriers [34] - The company expects to see increased user engagement and lifetime value as insurance coverage expands [36] Financial Guidance and Debt Management - For fiscal 2026, Teladoc anticipates revenue growth driven by insurance scaling and international growth, with projected insurance revenues of $75 million to $90 million [43] - The company plans to pay down a significant portion of its $1 billion debt due next year, leveraging existing cash and traditional term debt [51][52] Market Position and Competitive Landscape - The company views recent M&A activity in the behavioral health space as validation of the demand for virtual mental health services [39] - Teladoc has a strong market position with over 12,000 clients and a significant data advantage, which is crucial for AI deployment in healthcare [55] AI and Future Outlook - Teladoc is actively investing in AI to enhance engagement and service delivery, leveraging its extensive data to improve clinical interventions [54][56] - The company believes its deep expertise in healthcare and regulatory knowledge creates competitive moats in the telehealth industry [56] Additional Insights - The transition to visit-based revenues is seen as beneficial for service engagement, despite some initial headwinds from the subscription model [25] - The company is focused on operational efficiency and cost management to drive EBITDA results [43]

Core Insights - Teladoc Health, Inc. reported a solid finish for 2025, with consolidated revenue and adjusted EBITDA exceeding guidance for the fourth quarter [3][4] - The company is focused on disciplined execution and performance acceleration, aiming to enhance care delivery and outcomes through product innovation and technology advancements [4] Financial Performance - Fourth Quarter 2025 revenue was $642.3 million, a slight increase from $640.5 million in Fourth Quarter 2024, while Full Year 2025 revenue decreased by 2% to $2,530.0 million from $2,569.6 million in Full Year 2024 [5][10] - Net loss for Fourth Quarter 2025 was $25.1 million, or $0.14 per share, a significant improvement from a net loss of $48.4 million, or $0.28 per share, in Fourth Quarter 2024; Full Year 2025 net loss was $200.3 million, or $1.14 per share, compared to $1,001.2 million, or $5.87 per share, in Full Year 2024 [6][11] - Adjusted EBITDA for Fourth Quarter 2025 was $83.8 million, up 12% year-over-year, while Full Year 2025 adjusted EBITDA decreased by 10% to $281.1 million [7][14] Revenue Breakdown - Access fees revenue in Fourth Quarter 2025 decreased by 4% to $521.6 million, while other revenue increased by 24% to $120.7 million; U.S. revenue decreased by 3% to $517.3 million, and International revenue increased by 19% to $125.0 million [5][10] - For Full Year 2025, access fees revenue decreased by 6% to $2,091.9 million, while other revenue increased by 24% to $438.0 million; U.S. revenue decreased by 4% to $2,071.7 million, and International revenue increased by 12% to $458.2 million [10] Segment Performance - Integrated Care segment revenue increased by 5% to $409.1 million in Fourth Quarter 2025, while BetterHelp segment revenue decreased by 7% to $233.2 million [5][32] - For Full Year 2025, Integrated Care segment revenue increased by 3% to $1,579.6 million, while BetterHelp segment revenue decreased by 9% to $950.4 million [10][32] Cash Flow and Capital Expenditures - Operating cash flow for Full Year 2025 was $294.4 million, flat year-over-year, while free cash flow decreased by 2% to $166.9 million [7][15] - Capital expenditures for Full Year 2025 were $127.5 million, compared to $124.1 million in Full Year 2024 [15] Financial Outlook - For Full Year 2026, the company expects revenue between $2,470 million and $2,587 million, with adjusted EBITDA projected between $266 million and $308 million [18] - The first quarter of 2026 is expected to generate revenue between $598 million and $620 million, with adjusted EBITDA between $50 million and $62 million [19]

Transforming how better health happens J.P. Morgan Healthcare Conference January 2026 Safe Harbor This presentation contains, and the officers of Teladoc Health, Inc. (the "Company" or "Teladoc Health") may make, "forward-looking" statements that are based on management's beliefs and assumptions and on information currently available to management. These forward-looking statements include, without limitation, information concerning possible or assumed future results of operations, including descriptions of ...

Core Insights - Virtual care is becoming a mainstream healthcare channel, with Hims & Hers Health, Inc. (HIMS) and Teladoc Health, Inc. (TDOC) utilizing digital-first models to enhance access [2][3] Company Overview - HIMS operates as a consumer-first, subscription-based telehealth platform, allowing users to discover treatments online, consult licensed providers, and receive recurring prescriptions through its integrated digital pharmacy [2] - TDOC is a global leader in virtual care, providing services through its Integrated Care segment, which includes virtual medical visits and chronic care programs, as well as BetterHelp, its online therapy platform [2] Stock Performance & Valuation - Over the past three months, HIMS has decreased by 37.4%, while TDOC has declined by 9.7%. However, in the past year, HIMS has increased by 22.1%, contrasting with TDOC's loss of 22.5% [4] - HIMS is trading at a forward 12-month price-to-sales (P/S) ratio of 2.9X, above its three-year median of 2.6X, while TDOC's forward sales multiple is at 0.5X, below its median of 0.7X [6] Growth Strategies - HIMS is expanding into low testosterone care, integrating at-home lab testing with personalized treatment plans, and collaborating with Marius Pharmaceuticals to launch an exclusive branded oral testosterone by 2026 [8][10] - The introduction of Hims & Hers Labs aims to enhance customer engagement through diagnostics and biomarker tracking, supporting a more personalized healthcare model [9] - HIMS is also accelerating international expansion, having entered Canada and launched a Weight Loss Programme in the U.K. [10] Teladoc Health's Positioning - TDOC is focusing on building an integrated enterprise-scale virtual care platform, enhancing its offerings in primary care, chronic condition management, and mental health [11] - The company is expanding its hospital capabilities, introducing new tools for operational support and care-team workflows, with a new workplace safety capability expected to launch in early 2026 [12] - TDOC is working on stabilizing performance and improving execution across its segments, with recent results reflecting steady progress [13] Earnings Projections - The Zacks Consensus Estimate for HIMS' 2025 earnings per share (EPS) suggests a 77.8% improvement from 2024 [15] - For TDOC, the 2025 loss per share is expected to improve by 79.7% from 2024 [17] Price Targets - Analysts project an average price target of $45.92 for HIMS, indicating a potential increase of 31.9% from the last close [19] - For TDOC, the average price target is $9.18, suggesting a 27.3% increase from the last close [20] Investment Recommendation - HIMS is viewed as a more stable and financially sound investment opportunity due to its expanding specialty offerings and international growth strategy [22] - TDOC remains a leading enterprise-focused provider but is more exposed to demand cycles and segment-level volatility [23]

Core Insights - CareView Communications has announced a new partnership with Springfield Memorial Hospital to enhance patient care through innovative virtual monitoring solutions [1][4] - The collaboration aims to improve patient engagement, staff efficiency, and create safer care environments amid increasing pressures on hospitals to improve outcomes [2][4] Company Overview - CareView Communications is a leading provider of virtual care and patient safety solutions, having empowered over 200 hospitals across the U.S. with its technology [8] - The company focuses on reducing patient falls and alleviating staffing pressures through AI-enabled predictive tools [8] Partnership Details - Springfield Memorial Hospital will implement CareView's Virtual Sitting platform, which supports continuous observation and aims to reduce patient falls and strengthen workflow efficiencies [3][4] - The partnership reflects a shared commitment to investing in advanced technology that delivers meaningful clinical and financial impact [2][6] Implementation and Support - CareView will provide clinical training, 24/7 support, and dedicated program oversight to ensure a seamless deployment of the Virtual Observer platform at Springfield Memorial Hospital [6] - The agreement emphasizes the importance of aligning technology solutions with the hospital's long-term strategy for safe, high-quality care [5]

Core Insights - Teladoc Health, Inc. (TDOC) is enhancing its virtual care offerings by integrating TytoCare's FDA-approved Home Smart Clinic into its Primary360 and 24/7 Care programs, starting in 2026, allowing members to access clinical-grade remote exams [1][9] - TytoCare's technology enables comprehensive remote assessments of various health metrics, including lung and heart sounds, with its AI-powered Lung Sounds Suite recognized as a significant innovation [2][9] - This integration aims to strengthen TDOC's competitive position in the telehealth market, potentially leading to quicker interventions and improved chronic care management for conditions like asthma and hypertension [3][4] Company Developments - The integration of TytoCare's diagnostic tools is a response to the increasing demand for at-home healthcare solutions, indicating a shift towards more accessible diagnostics [4][9] - TDOC's cautious rollout strategy, starting with a select group of customers, suggests a focus on testing adoption and reimbursement alignment to ensure successful implementation [5] Market Performance - Year-to-date, TDOC shares have declined by 23%, contrasting with the industry's growth of 4.9%, highlighting the challenges faced by the company in the current market environment [8]

Core Insights - Omada Health will begin prescribing GLP-1s and other obesity medications, expanding its weight management program as membership surpasses 100,000 [1][6] Industry Overview - The digital health sector is increasingly entering the GLP-1 market, which could reach approximately $100 billion by the end of the decade [2] - Major manufacturers like Eli Lilly and Novo Nordisk are working to enhance accessibility and develop new treatments for obesity and chronic conditions [2] Company Strategy - Omada's CEO, Sean Duffy, believes that access to GLP-1s will significantly increase over time, with a market expansion expected to include pills and next-generation treatments [3] - The company aims to support lifestyle and behavioral changes for patients on GLP-1s, providing resources such as nutrition guidance and health coaching [4] Patient Support - The new offering will assist patients from the prescription stage through their treatment, addressing complexities and side effects associated with GLP-1 injections [5] - Omada collaborates with licensed providers trained in obesity care to enhance medication management for patients [4][5] Financial and Operational Context - Omada partners with health plans and employers to better support employee health needs while managing costs related to obesity treatments [6] - The company reported its quarterly earnings for the second time since its IPO in June [6][7]

Financial Data and Key Metrics Changes - Consolidated revenue for Q3 2025 was $626 million, a decline of 2.2% year over year, with adjusted EBITDA of $70 million representing an 11.2% margin [16][17] - Net loss per share was $0.28, which included a non-cash goodwill impairment charge of $0.07 per share pre-tax [16][17] - Free cash flow was $68 million in Q3, bringing year-to-date free cash flow to $113 million, with cash and cash equivalents at $726 million, an increase of $47 million sequentially [17][25] Business Line Data and Key Metrics Changes - Integrated Care revenue was $390 million, up 1.5% year over year, with U.S. Integrated Care membership at 102.5 million, a 9% increase year over year [17][18] - Chronic care program enrollment grew 4% sequentially, reaching 1.17 million [18] - BetterHelp segment revenue was $236.9 million, with average paying users declining 4% year over year to 382,000 [19][20] Market Data and Key Metrics Changes - International integrated care revenues grew 14% year over year on a constant currency basis [12] - The acquisitions of Catapult and Telecare contributed approximately 245 basis points to Integrated Care segment growth [18] Company Strategy and Development Direction - The company is focusing on integrated care, emphasizing performance, innovation, and client impact, with over 100 million people having access to its services [4][8] - The shift towards fee-for-service visit models is evident, with visit-based revenues now comprising over 50% of U.S. virtual care revenues [8] - The company aims to leverage its scaled mental health position and is excited about the new employee assistance program offering called Wellbound [9][10] Management's Comments on Operating Environment and Future Outlook - Management acknowledged substantial challenges in healthcare, including affordability, rising costs, and unmet mental health needs, while expressing commitment to driving the next evolution of virtual care [14][15] - The company expects 2025 consolidated revenue of $2.510 billion to $2.539 billion and adjusted EBITDA of $270 million to $287 million, with a focus on maintaining strong cash flow generation [21][24] Other Important Information - The company achieved ISO 9001 certification for key processes within U.S. integrated care, reflecting operational excellence [12] - The company was recognized as one of Time magazine's top health tech companies of 2025, highlighting its innovative contributions to healthcare [26] Q&A Session Summary Question: Insights on 2026 Selling Season - Management characterized 2025 as a repositioning year, focusing on driving higher performance and product innovation, with positive discussions with clients regarding new products and services for 2026 [29][30][32] Question: BetterHelp Margins and Transition to Insurance - Management indicated that BetterHelp margins are impacted by the transition to insurance offerings, with expectations for improved margins as the insurance business scales [34][36][67] Question: Chronic Care Enrollment Trends - Management expressed satisfaction with the sequential growth in chronic care enrollment and highlighted opportunities for further engagement and clinical interventions [78][81]

Core Insights - Omada Health has appointed Dr. Thomas Tsang as Chief Medical Officer to lead its clinical organization and enhance clinical quality and innovation [1][2][4] Company Overview - Omada Health is a virtual-first healthcare provider focused on chronic conditions such as diabetes, hypertension, and musculoskeletal issues, serving over 2,000 customers including health plans and Fortune 500 companies [5][6] - The company has implemented clinically-validated behavior change protocols and has over a decade of experience with 30 peer-reviewed publications demonstrating its clinical and economic results [5] Leadership and Experience - Dr. Tsang has a strong background in virtual care delivery, having previously served as founding CEO of Valera Health, where he raised over $75 million and scaled the company to over 500 employees [2][3] - His experience includes roles as Chief Medical Officer at Merck Healthcare Services and as a Medical Director under the Obama Administration, contributing to national health policy and electronic health records [3] Strategic Initiatives - Omada is expanding its GLP-1 Care Track, which has served over 100,000 members since its launch, and enhancing its AI capabilities with tools like OmadaSpark and Meal Map for personalized nutrition [4] - The company aims to combine innovative technology with human-led care to improve member engagement and health outcomes [4]

Core Insights - Teladoc Health Inc. will release its third quarter 2025 results on October 29, 2025, after market close [1] - A conference call to discuss the results will take place at 5:00 p.m. ET on the same day [1] Conference Call Details - U.S. participants can access the conference call by dialing 1-833-470-1428 with access code 609817 [2] - International participants can find global dial-in numbers through a provided link [2] - A live audio webcast will be available online for those who prefer to listen via the internet [2] Replay Information - A replay of the conference call will be available shortly after its completion and will remain accessible for approximately 90 days [3] Company Overview - Teladoc Health is recognized as the global leader in virtual care, focusing on delivering and orchestrating care across various stakeholders [4] - The company aims to enhance access, improve health outcomes, extend provider capacity, and reduce costs through its extensive relationships with health plans, employers, providers, health systems, and consumers [4]